Apollon Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Apollon Wealth Management, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $11.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$11.5M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 35,667 | $5.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,831 | $3.0M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 16,556 | $914K |
| SNYSanofi | 14,503 | $699K |
| PTCTPTC THERAPEUTICS, INC. | 7,339 | $500K |
| MRNAModerna, Inc. | 6,842 | $348K |
| HURATuHURA Biosciences, Inc./NV | 158,010 | $283K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 767 | $254K |
| TEVATeva Pharmaceutical Industries Limited | 8,226 | $248K |
| LQDALiquidia Corp | 6,535 | $247K |
| FLNAFilana Therapeutics Inc. | 35,053 | $59K |
| EVOEvotec SE | 11,168 | $28K |
| AUTLAutolus Therapeutics plc | 14,003 | $19K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.